ID   HMY-1
AC   CVCL_2950
SY   HMY1
DR   cancercelllines; CVCL_2950
DR   Cell_Model_Passport; SIDM01623
DR   DepMap; ACH-001522
DR   EFO; EFO_0006582
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472869
DR   CLS; 305145
DR   EGA; EGAS00001000610
DR   JCRB; JCRB1018
DR   JCRB; NIHS0252
DR   PharmacoDB; HMY1_556_2019
DR   Wikidata; Q54889978
RX   PubMed=6239887;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=6239887).
CC   HLA typing: A*02:06,24:02; B*39:01,52:01; C*07:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap).
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Discontinued: JCRB; NIHS0252; true.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): DepMap; JCRB; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 14,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,14
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 14
ST   Penta E: 17,20
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 26
//
RX   PubMed=6239887; DOI=10.1111/j.1346-8138.1984.tb01486.x;
RA   Kondo S., Sato N., Sato K., Hozumi Y., Aso K.;
RT   "Establishment of cell lines from human malignant melanomas and their
RT   application to the assessment of natural killer-like cytotoxicity.";
RL   J. Dermatol. 11:328-334(1984).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//